David Perry (entrepreneur): Difference between revisions
PaulCHebert (talk | contribs) |
m Re-submitted, after discussing with WP Editor PaulCHerbert via WP talk; resubmission has been rewritten to be less promotional sounding - just facts, all backed by top citations. |
||
Line 1: | Line 1: | ||
{{Infobox person |
{{Infobox person |
||
| name = David Perry |
| name = David Perry |
||
| image = [[File:DavidPerryIndigo.jpg|thumb|right|David Perry - President, CEO and Director, Indigo Agriculture]] |
|||
| education = [[University of Tulsa]] <br> [[Harvard University]] <br> [[United States Air Force Academy]] |
| education = [[University of Tulsa]] <br> [[Harvard University]] <br> [[United States Air Force Academy]] |
||
| occupation = Entrepreneur |
| occupation = Entrepreneur |
||
| employer = [[Indigo Agriculture]] |
| employer = [[Indigo Agriculture]] |
||
| boards = [[Indigo Agriculture]] <br> |
| boards = [[Indigo Agriculture]] <br> Better Therapeutics |
||
}}'''David Perry''' is |
}}'''David Perry''' is a [[technology]] [[entrepreneur]] in the [[food]] and [[agriculture]] sectors.<ref name="anacor">{{Cite web|url=http://www.bizjournals.com/sanfrancisco/blog/biotech/2014/03/anacor-david-perry-anac-kerydin-onychomycosis.html|title=Anacor Pharmaceuticals loses its CEO months before FDA drug decision - San Francisco Business Times|website=San Francisco Business Times|access-date=2016-03-23}}</ref> He has founded and built five innovative companies in the past 20 years, leading two ([[Anacor Pharmaceuticals]] and [[Chemdex]]) through [[IPO]]s to multibillion-dollar market capitalizations.<ref name="anacor">{{Cite web|url=http://www.bizjournals.com/sanfrancisco/blog/biotech/2014/03/anacor-david-perry-anac-kerydin-onychomycosis.html|title=Anacor Pharmaceuticals loses its CEO months before FDA drug decision - San Francisco Business Times|website=San Francisco Business Times|access-date=2016-03-23}}</ref><ref>{{Cite web|url=http://knowledge.wharton.upenn.edu/article/the-chemdex-approach-to-b2b-e-commerce/|title=The Chemdex Approach to B2B E-Commerce - Knowledge@Wharton|website=Knowledge@Wharton|language=en-US|access-date=2016-03-23}}</ref> |
||
Perry currently serves as the President, CEO, and Director of [[Indigo Agriculture]],<ref name=":0">{{Cite web|url=http://fortune.com/2016/02/18/microbiome-bacteria-indigo/|title=This Startup Wants to Use Bacteria to Revolutionize How Our Food Is Produced|website=Fortune|access-date=2016-03-23}}</ref> an agriculture company valued at over $1B.<ref>{{Cite web|url=https://www.bizjournals.com/memphis/news/2017/12/06/agtech-firm-with-memphis-office-closes-203m.html|title=Ag Tech Firm with Memphis Office Closes $203 Million|website=BizJournals.com|language=en-US|access-date=2017-12-06}}</ref> |
|||
He also co-founded Better Therapeutics (f/k/a FareWell), a digital therapeutic company for which he currently serves as Chairman of the Board.<ref>{{Cite web|url=http://mobihealthnews.com/content/farewell-raises-85m-digital-coaching-weight-loss-service|title=FareWell raises $8.5M for digital coaching weight loss service|date=2016-06-23|access-date=2016-08-17}}</ref><ref name=":1">{{Cite web|url=https://www.crunchbase.com/person/david-perry-2#/entity|title=David Perry - {{!}} CrunchBase|website=www.crunchbase.com|access-date=2016-03-23}}</ref> Additionally, he is a board member at Evelo Biosciences.<ref>{{Cite web|url=http://www.genengnews.com/gen-news-highlights/evelo-epiva-merge-to-develop-immuno-microbiome-therapies/81252942/|title=Evelo, Epiva Merge to Develop Immuno-Microbiome Therapies {{!}} GEN News Highlights {{!}} GEN|website=GEN|access-date=2016-08-17}}</ref> |
|||
==Early Life and Education== |
|||
Perry was raised on a farm in rural [[Arkansas]] and is a “serial entrepreneur,”<ref name=":0" /> founding several companies in the life sciences sector, including [[Anacor|Anacor Pharmaceuticals]],<ref>{{Cite web|url=http://www.bizjournals.com/sanfrancisco/blog/biotech/2014/03/anacor-david-perry-anac-kerydin-onychomycosis.html|title=Anacor Pharmaceuticals loses its CEO months before FDA drug decision - San Francisco Business Times|website=San Francisco Business Times|access-date=2016-03-23}}</ref> which he co-founded in 2002,<ref>{{Cite news|url=https://www.reuters.com/article/agriculture-symbiota-ceo-idUSL1N0UK12620150107|title=Start-up U.S. crop company snags pharmaceutical executive as CEO|date=2015-01-07|newspaper=Reuters|access-date=2016-03-23}}</ref> and Chemdex, a B2B platform for buyers and sellers of life science products.<ref>{{Cite web|url=http://knowledge.wharton.upenn.edu/article/the-chemdex-approach-to-b2b-e-commerce/|title=The Chemdex Approach to B2B E-Commerce - Knowledge@Wharton|website=Knowledge@Wharton|language=en-US|access-date=2016-03-23}}</ref> |
|||
Perry was raised on a farm in rural [[Arkansas]]. His began his career at [[Exxon]], where he managed the operations and maintenance of a $200 million unit of an oil refinery.<ref name="DPGreen">{{Cite web|url=https://www.alumni.hbs.edu/stories/Pages/story-bulletin.aspx?num=6569|title=David Perry's Green Revolution|date=2018-02-20|access-date=2018-01-20}}</ref> |
|||
⚫ | Perry holds a BS from the [[University of Tulsa]] and an MBA from [[Harvard Business School]].<ref name="DPGreen">{{Cite web|url=https://www.alumni.hbs.edu/stories/Pages/story-bulletin.aspx?num=6569|title=David Perry's Green Revolution|date=2018-02-20|access-date=2018-01-20}}</ref> He also attended the [[United States Air Force Academy]], where he was selected as a [[National Merit Scholar]].<ref>{{Cite web|url=https://www.bloomberg.com/research/stocks/people/person.asp?personId=131924&privcapId=3451109|title=List of Public Companies Worldwide, Letter - Businessweek - Businessweek|website=Businessweek.com|access-date=2016-03-23}}</ref> |
||
==Entrepreneurship== |
|||
Under Perry’s leadership, Chemdex, rebranded as Ventro in 2000, achieved a valuation of $11 billion.<ref>{{Cite news|url=http://articles.latimes.com/2001/jun/24/business/fi-14133|title=Fatal Flaw Dooms an Internet Venture|last=PILLER|first=CHARLES|date=2001-06-24|newspaper=Los Angeles Times|language=en-US|issn=0458-3035|access-date=2016-03-23}}</ref> |
|||
===Virogen=== |
|||
While at [[Harvard Business School]], Perry founded Virogen, a [[biotechnology]] company focused on [[diagnostics]].<ref>{{Cite web|url=https://www.twst.com/interview/david-perry-ventro-corporation-vntr|title=David Perry - Ventro Corporation (vntr) - The Wall Street Transcript|website=The Wall Street Transcript|language=en-US|access-date=2016-03-23}}</ref> |
|||
===Chemdex=== |
|||
He then founded [[Chemdex]], a [[B2B]] marketplace focusing on the life-sciences industry. Perry grew the company from inception to 500 employees, raised $46M in venture financing and led the company through a successful $130 million [[IPO]].<ref>{{Cite web|url=https://scrip.pharmaintelligence.informa.com/SC091270/Lessons-Learned-David-Perry-from-Chemdex-to-Anacorl|title=Lessons Learned from Chemdex to Anacor|date=2006-01-01|access-date=2006-01-01}}</ref><ref>{{Cite web|url=https://www.forbes.com/forbes/2000/0221/6504126a.html#39b08f8f702f|title=Good Chemistry|date=2002-02-21|access-date=2002-02-21}}</ref><ref>{{Cite web|url=https://www.cnet.com/news/chemdex-shines-on-market-debut/|title=Chemdex Shines on Market Debut|date=2002-01-02|access-date=2002-01-02}}</ref> |
|||
===Anacor=== |
|||
In 2002, Perry co-founded [[Anacor]] and served as its CEO for twelve years. He grew the startup through a 2010 IPO and a multibillion-dollar valuation.<ref>{{Cite web|url=https://www.bloomberg.com/research/stocks/people/person.asp?personId=131924&privcapId=131917|title=David Perry: Executive Bio|date=2017-01-01|access-date=2017-01-01}}</ref> The [[biopharmaceutical]] company is focused on developing novel small-molecule [[therapeutics]] to treat infectious and [[inflammatory diseases]]. In 2016, the company was acquired by [[Pfizer]] for $5.4 billion.<ref>{{Cite web|url= https://www.reuters.com/article/us-anacor-pharma-m-a-pfizer-analysis/pfizer-to-buy-anacor-in-5-2-billion-deal-for-access-to-eczema-gel-idUSKCN0Y7143|title=Pfizer to Buy Anacor in $5.4 Billion Deal|date=2016-05-17|access-date=2016-05-17}}</ref> |
|||
===Better Therapeutics=== |
|||
Perry co-founded Better Therapeutics (f/k/a FareWell), a digital therapeutics company focused on preventing and reversing chronic disease through lifestyle changes, in 2015.<ref name="farewell">{{Cite web|url=https://venturebeat.com/2016/06/22/farewell-raises-8-5m-to-provide-dietary-lifestyle-intervention-program-to-those-at-risk-of-chronic-weight-related-diseases/|title=FareWell Raises $8.5M to Provide Dietary Lifestyle Intervention Program to Those at Risk of Chronic, Weight-Related Diseases|date=2016-06-22|access-date=2016-06-22}}</ref> Better Therapeutics believes non-drug treatment options can reduce health and cost burdens of chronic disease.<ref name="farewell">{{Cite web|url=https://venturebeat.com/2016/06/22/farewell-raises-8-5m-to-provide-dietary-lifestyle-intervention-program-to-those-at-risk-of-chronic-weight-related-diseases/|title=FareWell Raises $8.5M to Provide Dietary Lifestyle Intervention Program to Those at Risk of Chronic, Weight-Related Diseases|date=2016-06-22|access-date=2016-06-22}}</ref> |
|||
===Indigo Agriculture=== |
|||
⚫ | |||
In 2015, Perry began his current role as President, Director, and [[Chief Executive Officer]] of [[Indigo Agriculture]], a company dedicated to harnessing nature to help farmers sustainably feed the planet.<ref name="foodsec">{{Cite web|url=https://harvardmagazine.com/2018/03/sustainable-agriculture-and-food-security|title=Sustainable Agriculture and Food Security|date=2018-03-01|access-date=2018-03-01}}</ref> The company utilizes beneficial [[microbes]] residing within plant tissues to improve crop health and productivity.<ref>{{Cite web|url= https://innovator.news/startup-of-the-week-indigo-agriculture-49f9f7b5f7c7|title=Startup of the Week: Indigo Agriculture|date=2017-10-15|access-date=2017-10-15}}</ref> Indigo also contracts with growers to purchase their crops at a premium.<ref name="foodsec">{{Cite web|url=https://harvardmagazine.com/2018/03/sustainable-agriculture-and-food-security|title=Sustainable Agriculture and Food Security|date=2018-03-01|access-date=2018-03-01}}</ref> |
|||
As of March 2018, Perry led the largest private funding round secured in [[agriculture]] [[technology]]: a $203 million funding round for Indigo in December 2017.<ref>{{Cite web|url=https://www.reuters.com/article/us-indigo-fundraising/farming-startup-indigo-raises-203-million-with-help-from-dubai-fund-idUSKBN1E01PK|title=Farming Startup Indigo Raises $203 Million|date=2017-12-06|access-date=2017-12-06}}</ref> To date, Indigo has raised over $400 million in funding, bringing the company’s total valuation to over $1 billion and earning it the distinction of being the first “unicorn” in agriculture.<ref>{{Cite web|url=https://agfundernews.com/top-10-farm-tech-deals-of-2017.html|title=Top 10 Farm tech Deals of 2017|date=2017-12-21|access-date=2017-12-21}}</ref><ref>{{Cite web|url=https://www.builtinboston.com/2018/01/02/boston-top-fundings-december-2017|title=Top 5 Boston Funding Rounds on 2017|date=2018-01-02|access-date=2017-01-02}}</ref> |
|||
== Awards and Recognitions== |
|||
== Education == |
|||
Indigo Ag was named a 2017 World Economic Forum Technology Pioneer.<ref name="WEF">{{Cite web|url=https://www.weforum.org/agenda/authors/david-perry/|title=World Economic Forum|date=2018-01-01|access-date=2018-01-01}}</ref> |
|||
⚫ | Perry holds a BS from the [[University of Tulsa]] and |
||
Perry was named Entrepreneur of the Year by financial consulting firm [[Ernst & Young]].<ref>{{Cite web|url=https://agfundernews.com/indigo-ceo-david-perry-discusses-name-change-and-raising-56m-series-b5444.html|title=Indigo CEO David Perry Discusses Name Change and Raising $56mm Series B|date=2016-03-01|access-date=2016-03-01}}</ref><ref name="WEF">{{Cite web|url=https://www.weforum.org/agenda/authors/david-perry/|title=World Economic Forum|date=2018-01-01|access-date=2018-01-01}}</ref><ref name=":1">{{Cite web|url=https://www.crunchbase.com/person/david-perry-2|title=Crunchbase Profile: David Perry|date=2018-01-01|access-date=2018-01-01}}</ref> |
|||
Flagship Pioneering gave Perry its 2017 Pioneering Leader Award for his “commitment to innovations transforming the future of farming.”<ref>{{Cite web|url=http://flagshippioneering.com/news/flagship-pioneering-names-david-perry-ceo-indigo-agriculture-recipient-2017-pioneering-leader-award/|title=Flagship Pioneering Names David Perry CEO Indigo Agriculture 2017 Pioneering Leader Award|date=2017-11-16|access-date=2017-11-16}}</ref> |
|||
⚫ | He has also been called “one of the rock stars of the Web” by Pharma & MedTech Business Intelligence.<ref>{{Cite web|url=https://www.pharmamedtechbi.com/publications/start-up/11/6/lessons-learned-david-perry-from-chemdex-to-anacor|title=Lessons Learned: David Perry, from Chemdex to Anacor :: START-UP :: Pharma & Medtech Business Intelligence|website=www.pharmamedtechbi.com|access-date=2016-03-23}}</ref> |
||
== References == |
== References == |
||
{{Reflist}} |
{{Reflist}} |
||
{{Authority control}} |
{{Authority control}} |
||
{{DEFAULTSORT:Perry, David}} |
{{DEFAULTSORT:Perry, David}} |
||
[[Category:Year of birth missing (living people)]] |
[[Category:Year of birth missing (living people)]] |
Revision as of 15:50, 29 March 2018
David Perry | |
---|---|
Education | University of Tulsa Harvard University United States Air Force Academy |
Occupation | Entrepreneur |
Employer | Indigo Agriculture |
Board member of | Indigo Agriculture Better Therapeutics |
David Perry is a technology entrepreneur in the food and agriculture sectors.[1] He has founded and built five innovative companies in the past 20 years, leading two (Anacor Pharmaceuticals and Chemdex) through IPOs to multibillion-dollar market capitalizations.[1][2]
Perry currently serves as the President, CEO, and Director of Indigo Agriculture,[3] an agriculture company valued at over $1B.[4] He also co-founded Better Therapeutics (f/k/a FareWell), a digital therapeutic company for which he currently serves as Chairman of the Board.[5][6] Additionally, he is a board member at Evelo Biosciences.[7]
Early Life and Education
Perry was raised on a farm in rural Arkansas. His began his career at Exxon, where he managed the operations and maintenance of a $200 million unit of an oil refinery.[8] Perry holds a BS from the University of Tulsa and an MBA from Harvard Business School.[8] He also attended the United States Air Force Academy, where he was selected as a National Merit Scholar.[9]
Entrepreneurship
Virogen
While at Harvard Business School, Perry founded Virogen, a biotechnology company focused on diagnostics.[10]
Chemdex
He then founded Chemdex, a B2B marketplace focusing on the life-sciences industry. Perry grew the company from inception to 500 employees, raised $46M in venture financing and led the company through a successful $130 million IPO.[11][12][13]
Anacor
In 2002, Perry co-founded Anacor and served as its CEO for twelve years. He grew the startup through a 2010 IPO and a multibillion-dollar valuation.[14] The biopharmaceutical company is focused on developing novel small-molecule therapeutics to treat infectious and inflammatory diseases. In 2016, the company was acquired by Pfizer for $5.4 billion.[15]
Better Therapeutics
Perry co-founded Better Therapeutics (f/k/a FareWell), a digital therapeutics company focused on preventing and reversing chronic disease through lifestyle changes, in 2015.[16] Better Therapeutics believes non-drug treatment options can reduce health and cost burdens of chronic disease.[16]
Indigo Agriculture
In 2015, Perry began his current role as President, Director, and Chief Executive Officer of Indigo Agriculture, a company dedicated to harnessing nature to help farmers sustainably feed the planet.[17] The company utilizes beneficial microbes residing within plant tissues to improve crop health and productivity.[18] Indigo also contracts with growers to purchase their crops at a premium.[17] As of March 2018, Perry led the largest private funding round secured in agriculture technology: a $203 million funding round for Indigo in December 2017.[19] To date, Indigo has raised over $400 million in funding, bringing the company’s total valuation to over $1 billion and earning it the distinction of being the first “unicorn” in agriculture.[20][21]
Awards and Recognitions
Indigo Ag was named a 2017 World Economic Forum Technology Pioneer.[22] Perry was named Entrepreneur of the Year by financial consulting firm Ernst & Young.[23][22][6] Flagship Pioneering gave Perry its 2017 Pioneering Leader Award for his “commitment to innovations transforming the future of farming.”[24] He has also been called “one of the rock stars of the Web” by Pharma & MedTech Business Intelligence.[25]
References
- ^ a b "Anacor Pharmaceuticals loses its CEO months before FDA drug decision - San Francisco Business Times". San Francisco Business Times. Retrieved 2016-03-23.
- ^ "The Chemdex Approach to B2B E-Commerce - Knowledge@Wharton". Knowledge@Wharton. Retrieved 2016-03-23.
- ^ "This Startup Wants to Use Bacteria to Revolutionize How Our Food Is Produced". Fortune. Retrieved 2016-03-23.
- ^ "Ag Tech Firm with Memphis Office Closes $203 Million". BizJournals.com. Retrieved 2017-12-06.
- ^ "FareWell raises $8.5M for digital coaching weight loss service". 2016-06-23. Retrieved 2016-08-17.
- ^ a b "David Perry - | CrunchBase". www.crunchbase.com. Retrieved 2016-03-23. Cite error: The named reference ":1" was defined multiple times with different content (see the help page).
- ^ "Evelo, Epiva Merge to Develop Immuno-Microbiome Therapies | GEN News Highlights | GEN". GEN. Retrieved 2016-08-17.
- ^ a b "David Perry's Green Revolution". 2018-02-20. Retrieved 2018-01-20.
- ^ "List of Public Companies Worldwide, Letter - Businessweek - Businessweek". Businessweek.com. Retrieved 2016-03-23.
- ^ "David Perry - Ventro Corporation (vntr) - The Wall Street Transcript". The Wall Street Transcript. Retrieved 2016-03-23.
- ^ "Lessons Learned from Chemdex to Anacor". 2006-01-01. Retrieved 2006-01-01.
- ^ "Good Chemistry". 2002-02-21. Retrieved 2002-02-21.
- ^ "Chemdex Shines on Market Debut". 2002-01-02. Retrieved 2002-01-02.
- ^ "David Perry: Executive Bio". 2017-01-01. Retrieved 2017-01-01.
- ^ "Pfizer to Buy Anacor in $5.4 Billion Deal". 2016-05-17. Retrieved 2016-05-17.
- ^ a b "FareWell Raises $8.5M to Provide Dietary Lifestyle Intervention Program to Those at Risk of Chronic, Weight-Related Diseases". 2016-06-22. Retrieved 2016-06-22.
- ^ a b "Sustainable Agriculture and Food Security". 2018-03-01. Retrieved 2018-03-01.
- ^ "Startup of the Week: Indigo Agriculture". 2017-10-15. Retrieved 2017-10-15.
- ^ "Farming Startup Indigo Raises $203 Million". 2017-12-06. Retrieved 2017-12-06.
- ^ "Top 10 Farm tech Deals of 2017". 2017-12-21. Retrieved 2017-12-21.
- ^ "Top 5 Boston Funding Rounds on 2017". 2018-01-02. Retrieved 2017-01-02.
- ^ a b "World Economic Forum". 2018-01-01. Retrieved 2018-01-01.
- ^ "Indigo CEO David Perry Discusses Name Change and Raising $56mm Series B". 2016-03-01. Retrieved 2016-03-01.
- ^ "Flagship Pioneering Names David Perry CEO Indigo Agriculture 2017 Pioneering Leader Award". 2017-11-16. Retrieved 2017-11-16.
- ^ "Lessons Learned: David Perry, from Chemdex to Anacor :: START-UP :: Pharma & Medtech Business Intelligence". www.pharmamedtechbi.com. Retrieved 2016-03-23.